|
JP5435592B2
(ja)
|
2008-05-28 |
2014-03-05 |
ファイザー・インク |
ピラゾロスピロケトンアセチルＣｏＡカルボキシラーゼ阻害剤
|
|
EP2947082A1
(en)
|
2009-11-10 |
2015-11-25 |
Pfizer Inc |
N1-PYRAZOLOSPIROKETONE ACETYL-CoA CARBOXYLASE INHIBITORS
|
|
DK2547679T3
(en)
|
2010-03-19 |
2016-01-11 |
Pfizer |
2,3 dihydro-1H-inden-1-yl-2,7-diazaspiro [3.6] nonane derivatives and their use as antagonists or inverse agonists of ghrelin receptor
|
|
US9006450B2
(en)
*
|
2010-07-01 |
2015-04-14 |
Boehringer Ingelheim International Gmbh |
Compounds, pharmaceutical compositions and uses thereof
|
|
HRP20161178T1
(hr)
|
2010-09-30 |
2016-11-04 |
Pfizer Inc. |
N1-PIRAZOLOSPIROKETONSKI INHIBITORI ACETIL-CoA-KARBOKSILAZE
|
|
ES2546465T3
(es)
|
2010-10-29 |
2015-09-23 |
Pfizer Inc |
Inhibidores de N1/N2-lactama acetil-CoA carboxilasa
|
|
AU2012245996B2
(en)
|
2011-04-22 |
2016-09-01 |
Pfizer Inc. |
Pyrazolospiroketone derivatives for use as acetyl-CoA carboxylase inhibitors
|
|
JP2014520879A
(ja)
|
2011-07-15 |
2014-08-25 |
ファイザー・インク |
Ｇｐｒ１１９調節因子
|
|
US8927577B2
(en)
|
2011-07-22 |
2015-01-06 |
Pfizer Inc. |
Quinolinyl glucagon receptor modulators
|
|
JP6043355B2
(ja)
|
2011-08-31 |
2016-12-14 |
ファイザー・インク |
ヘキサヒドロピラノ［３，４−ｄ］［１，３］チアジン−２−アミン化合物
|
|
EP2567959B1
(en)
|
2011-09-12 |
2014-04-16 |
Sanofi |
6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
|
|
CN103917529B
(zh)
|
2011-11-11 |
2016-08-17 |
辉瑞大药厂 |
2-硫代嘧啶酮类
|
|
EA201400990A1
(ru)
|
2012-04-06 |
2015-01-30 |
Пфайзер Инк. |
Ингибиторы диацилглицеринацилтрансферазы 2
|
|
US8889730B2
(en)
|
2012-04-10 |
2014-11-18 |
Pfizer Inc. |
Indole and indazole compounds that activate AMPK
|
|
WO2013164730A1
(en)
|
2012-05-04 |
2013-11-07 |
Pfizer Inc. |
Heterocyclic substituted hexahydropyrano [3,4-d] [1,3] thiazin- 2 -amine compounds as inhibitors of app, bace1 and bace 2.
|
|
EP2897964A1
(en)
|
2012-09-20 |
2015-07-29 |
Pfizer Inc. |
Alkyl-substituted hexahydropyrano [3,4-d][1,3]thiazin-2-amine compounds
|
|
EP2931731A1
(en)
|
2012-12-11 |
2015-10-21 |
Pfizer Inc. |
Hexahydropyrano [3,4-d][1,3]thiazin-2-amine compounds as inhibitors of bace1
|
|
US9403846B2
(en)
|
2012-12-19 |
2016-08-02 |
Pfizer Inc. |
Carbocyclic- and heterocyclic-substituted hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds
|
|
EP2956458B1
(en)
|
2013-02-13 |
2017-08-09 |
Pfizer Inc |
Heteroaryl-substituted hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds
|
|
US9233981B1
(en)
|
2013-02-15 |
2016-01-12 |
Pfizer Inc. |
Substituted phenyl hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds
|
|
US20160220557A1
(en)
|
2013-09-12 |
2016-08-04 |
Pfizer Inc. |
Use of acetyl-coa carboxylase inhibitors for treating acne vulgaris
|
|
CA2926568C
(en)
|
2013-10-09 |
2017-09-05 |
Pfizer Inc. |
Antagonists of prostaglandin ep3 receptor
|
|
LT3119757T
(lt)
|
2014-03-17 |
2018-07-10 |
Pfizer Inc. |
Diacilglicerolio aciltransferazės 2 inhibitoriai, skirti panaudoti metabolinių ir susijusių ligų gydyme
|
|
DK3126330T3
(en)
|
2014-04-04 |
2019-04-23 |
Pfizer |
BICYCLE-FUSED HETEROARYL OR ARYL COMPOUNDS AND USE THEREOF AS IRAC4 INHIBITORS
|
|
CN106459088A
(zh)
|
2014-04-10 |
2017-02-22 |
辉瑞公司 |
2‑氨基‑6‑甲基‑4，4a，5，6‑四氢吡喃并[3，4‑d][1，3]噻嗪‑8a(8H)‑基‑1，3‑噻唑‑4‑基酰胺
|
|
JP6559228B2
(ja)
*
|
2014-09-17 |
2019-08-14 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
肥満症及び糖尿病の治療に有用なテトラヒドロイソキノリン誘導体及び医薬組成物
|
|
WO2016092413A1
(en)
|
2014-12-10 |
2016-06-16 |
Pfizer Inc. |
Indole and indazole compounds that activate ampk
|
|
EP3237401B1
(en)
|
2014-12-22 |
2019-03-06 |
Pfizer Inc |
Antagonists of prostaglandin ep3 receptor
|
|
AU2016257179A1
(en)
|
2015-05-05 |
2017-11-02 |
Pfizer Inc. |
2-thiopyrimidinones
|
|
US10308615B2
(en)
|
2015-05-29 |
2019-06-04 |
Pfizer Inc. |
Heterocyclic compounds as inhibitors of Vanin-1 enzyme
|
|
CN107787322B
(zh)
|
2015-06-17 |
2023-07-07 |
辉瑞大药厂 |
三环化合物以及它们作为磷酸二酯酶抑制剂的用途
|
|
WO2016203335A1
(en)
|
2015-06-18 |
2016-12-22 |
Pfizer Inc. |
Novel pyrido[2,3-b]pyrazinones as bet-family bromodomain inhibitors
|
|
WO2017025849A1
(en)
|
2015-08-13 |
2017-02-16 |
Pfizer Inc. |
Bicyclic-fused heteroaryl or aryl compounds
|
|
HUE053705T2
(hu)
|
2015-08-27 |
2021-07-28 |
Pfizer |
Biciklusos kondenzált heteroaril- vagy aril- vegyületek IRAK4 modulátorokként
|
|
WO2017037567A1
(en)
|
2015-09-03 |
2017-03-09 |
Pfizer Inc. |
Regulators of frataxin
|
|
JP2018534251A
(ja)
|
2015-09-24 |
2018-11-22 |
ファイザー・インク |
Ｂａｃｅ阻害剤として有用なｎ−［２−（３−アミノ−２，５−ジメチル−１，１−ジオキシド−５，６−ジヒドロ−２ｈ−１，２，４−チアジアジン−５−イル）−１，３−チアゾール−４−イル］アミド
|
|
WO2017051303A1
(en)
|
2015-09-24 |
2017-03-30 |
Pfizer Inc. |
Tetrahydropyrano[3,4-d][1,3]oxazin derivatives and their use as bace inhibitors
|
|
JP2018531923A
(ja)
|
2015-09-24 |
2018-11-01 |
ファイザー・インク |
Ｎ−［２−（２−アミノ−６，６−二置換−４，４ａ，５，６−テトラヒドロピラノ［３，４−ｄ］［１，３］チアジン−８ａ（８Ｈ）−イル）−１，３−チアゾール−４−イル］アミド
|
|
SI3397631T1
(sl)
|
2015-12-29 |
2022-01-31 |
Pfizer Inc. |
Substituirani 3-azabiciklo(3.1.0)heksani kot zaviralci ketoheksokinaze
|
|
CA3021140A1
(en)
|
2016-04-19 |
2017-10-26 |
Ureka Sarl |
Peptide-oligourea foldamer compounds and methods of their use
|
|
WO2018011681A1
(en)
|
2016-07-14 |
2018-01-18 |
Pfizer Inc. |
Novel pyrimidine carboxamides as inhibitors of vanin-1 enzyme
|
|
AR109179A1
(es)
|
2016-08-19 |
2018-11-07 |
Pfizer |
Inhibidores de diacilglicerol aciltransferasa 2
|
|
WO2019133445A1
(en)
|
2017-12-28 |
2019-07-04 |
Inception Ibd, Inc. |
Aminothiazoles as inhibitors of vanin-1
|
|
US11254660B2
(en)
|
2018-08-31 |
2022-02-22 |
Pfizer Inc. |
Combinations for treatment of NASH/NAFLD and related diseases
|
|
WO2020102575A1
(en)
|
2018-11-16 |
2020-05-22 |
Inception Ibd, Inc. |
Heterocyclic aminothiazoles and uses thereof
|
|
US12479816B2
(en)
|
2019-02-08 |
2025-11-25 |
University of Pittsburgh—of the Commonwealth System of Higher Education |
20-HETE formation inhibitors
|
|
WO2020234726A1
(en)
|
2019-05-20 |
2020-11-26 |
Pfizer Inc. |
Combinations comprising benzodioxol as glp-1r agonists for use in the treatment of nash/nafld and related diseases
|
|
CN110922372A
(zh)
*
|
2019-11-04 |
2020-03-27 |
天津大学 |
达格列净的氨基酸共晶物及其制备方法
|
|
HRP20241159T1
(hr)
|
2020-02-07 |
2024-12-06 |
Gasherbrum Bio, Inc. |
Heterociklički agonisti za glp-1
|
|
TW202206429A
(zh)
|
2020-04-29 |
2022-02-16 |
美商迦舒布魯姆生物有限公司 |
雜環ｇｌｐ—１促效劑
|
|
EP4154880A4
(en)
*
|
2020-05-21 |
2024-06-05 |
Shionogi & Co., Ltd |
Pharmaceutical for treating fatty liver diseases
|
|
JP2025509281A
(ja)
|
2022-03-09 |
2025-04-11 |
ガシャーブラム・バイオ・インコーポレイテッド |
ヘテロ環式ｇｌｐ－１アゴニスト
|
|
US20250250269A1
(en)
|
2022-04-14 |
2025-08-07 |
Gasherbrum Bio, Inc. |
Heterocyclic glp-1 agonists
|
|
WO2024118524A1
(en)
|
2022-11-28 |
2024-06-06 |
Cerevel Therapeutics, Llc |
Azaindole compounds and their use as phosphodiesterase inhibitors
|
|
TW202435857A
(zh)
|
2022-12-15 |
2024-09-16 |
美商迦舒布魯姆生物有限公司 |
具有glp-1促效劑活性之化合物之鹽及固體形式
|